These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 31823528)
1. [A COMPARISON BETWEEN TWO POTASSIUM CITRATE REGIMENS FOR THE TREATMENT OF NEPHROLITHIASIS]. Drori T; Abu-Ghanem Y; Kleinmann N; Shvero A; Winkler HZ; Zilberman DE Harefuah; 2019 Dec; 158(12):774-777. PubMed ID: 31823528 [TBL] [Abstract][Full Text] [Related]
2. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation. Robinson MR; Leitao VA; Haleblian GE; Scales CD; Chandrashekar A; Pierre SA; Preminger GM J Urol; 2009 Mar; 181(3):1145-50. PubMed ID: 19152932 [TBL] [Abstract][Full Text] [Related]
3. [Clinical study of Urocit-K: a slow releasing potassium citrate]. Hwang TI; Yang CR; Lai LH Zhonghua Yi Xue Za Zhi (Taipei); 1992 Mar; 49(3):194-8. PubMed ID: 1316212 [TBL] [Abstract][Full Text] [Related]
4. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children. Sarica K; Erturhan S; Yurtseven C; Yagci F J Endourol; 2006 Nov; 20(11):875-9. PubMed ID: 17144854 [TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of stone formers treated with a low dose of sodium potassium citrate. Jendle-Bengten C; Tiselius HG Scand J Urol Nephrol; 2000 Feb; 34(1):36-41. PubMed ID: 10757268 [TBL] [Abstract][Full Text] [Related]
6. Urinary citrate and renal stone disease: the preventive role of alkali citrate treatment. Caudarella R; Vescini F Arch Ital Urol Androl; 2009 Sep; 81(3):182-7. PubMed ID: 19911682 [TBL] [Abstract][Full Text] [Related]
7. Effects of the association of potassium citrate and agropyrum repens in renal stone treatment: results of a prospective randomized comparison with potassium citrate. Brardi S; Imperiali P; Cevenini G; Verdacchi T; Ponchietti R Arch Ital Urol Androl; 2012 Jun; 84(2):61-7. PubMed ID: 22908773 [TBL] [Abstract][Full Text] [Related]
8. Alkaline citrate reduces stone recurrence and regrowth after shockwave lithotripsy and percutaneous nephrolithotomy. Lojanapiwat B; Tanthanuch M; Pripathanont C; Ratchanon S; Srinualnad S; Taweemonkongsap T; Kanyok S; Lammongkolkul S Int Braz J Urol; 2011; 37(5):611-6. PubMed ID: 22099273 [TBL] [Abstract][Full Text] [Related]
9. Lemonade therapy increases urinary citrate and urine volumes in patients with recurrent calcium oxalate stone formation. Penniston KL; Steele TH; Nakada SY Urology; 2007 Nov; 70(5):856-60. PubMed ID: 17919696 [TBL] [Abstract][Full Text] [Related]
11. [Effect of potassium citrate in the prophylaxis of urinary lithiasis]. Jiménez Verdejo A; Arrabal Martín M; Miján Ortiz JL; Hita Rosino E; Palao Yago F; Zuluaga Gómez A Arch Esp Urol; 2001 Nov; 54(9):1036-46. PubMed ID: 11789361 [TBL] [Abstract][Full Text] [Related]
12. Dissolution of radiolucent renal stones by oral alkalinization with potassium citrate/potassium bicarbonate. Trinchieri A; Esposito N; Castelnuovo C Arch Ital Urol Androl; 2009 Sep; 81(3):188-91. PubMed ID: 19911683 [TBL] [Abstract][Full Text] [Related]
13. The effects of potassium and magnesium supplementations on urinary risk factors of renal stone patients. Jaipakdee S; Prasongwatana V; Premgamone A; Reungjui S; Tosukhowong P; Tungsanga K; Suwantrai S; Noppawinyoowong C; Maskasame S; Sriboonlue P J Med Assoc Thai; 2004 Mar; 87(3):255-63. PubMed ID: 15117041 [TBL] [Abstract][Full Text] [Related]
14. Comparison between lemonade and potassium citrate and impact on urine pH and 24-hour urine parameters in patients with kidney stone formation. Koff SG; Paquette EL; Cullen J; Gancarczyk KK; Tucciarone PR; Schenkman NS Urology; 2007 Jun; 69(6):1013-6. PubMed ID: 17572176 [TBL] [Abstract][Full Text] [Related]
15. Effect of Potassium Citrate on Calcium Phosphate Stones in a Model of Hypercalciuria. Krieger NS; Asplin JR; Frick KK; Granja I; Culbertson CD; Ng A; Grynpas MD; Bushinsky DA J Am Soc Nephrol; 2015 Dec; 26(12):3001-8. PubMed ID: 25855777 [TBL] [Abstract][Full Text] [Related]
16. Litholytic property of Kulattha (Dolichous biflorus) vs potassium citrate in renal calculus disease: a comparative study. Singh RG; Behura SK; Kumar R J Assoc Physicians India; 2010 May; 58():286-9. PubMed ID: 21117346 [TBL] [Abstract][Full Text] [Related]
17. Potassium-sodium citrate prevents the development of renal microcalculi into symptomatic stones in calcium stone-forming patients. Unno R; Taguchi K; Okada A; Ando R; Hamamoto S; Kubota Y; Zuo L; Tozawa K; Kohri K; Yasui T Int J Urol; 2017 Jan; 24(1):75-81. PubMed ID: 27747937 [TBL] [Abstract][Full Text] [Related]
18. Renal tubular cell damage and oxidative stress in renal stone patients and the effect of potassium citrate treatment. Tungsanga K; Sriboonlue P; Futrakul P; Yachantha C; Tosukhowong P Urol Res; 2005 Feb; 33(1):65-9. PubMed ID: 15565439 [TBL] [Abstract][Full Text] [Related]
19. Effect of potassium citrate therapy on stone recurrence and residual fragments after shockwave lithotripsy in lower caliceal calcium oxalate urolithiasis: a randomized controlled trial. Soygür T; Akbay A; Küpeli S J Endourol; 2002 Apr; 16(3):149-52. PubMed ID: 12028622 [TBL] [Abstract][Full Text] [Related]
20. Effect of blind treatment on stone disease. Fazil Marickar YM; Salim A; Vijay A Urol Res; 2010 Jun; 38(3):205-9. PubMed ID: 19997722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]